Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The once hard-to-get prescription drug is now widely popular, but still expensive
By mid-April, total prescriptions had exceeded 200,000 per week and passed 2 million since launch
has been on the advisory panel of, a consultant for, in the speaker's bureau of, owns shares in, and/or has received research support from 89bio, AstraZeneca, Boehringer Ingelheim, Cytoki Pharma, Eli Lilly, Gubra, Novo Nordisk, Merck Sharp & Dohme, Sanofi, Structure Therapeutics, Zealand Pharma, and Zucara
Incapsula incident ID: 326000850120431228-31553239254439239
US$ 28.30
US$ 24.33
US$ 20.34
US$ 25.86
US$ 21.49
